STOCKHOLM, Sweden, May 4, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical reports that the respected scientific journal Diabetologia has published an article containing the results of a study demonstrating that the Diamyd(r) vaccine significantly reduces the risk that patients with LADA (Latent Autoimmune Diabetes in Adults) will require treatment with insulin still after five years. The results that now have been published, were previously presented at the EASD meeting in Rome, August 2008.
